| 142.69 0.25 (0.18%) | 05-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 168.1  |
1-year : | 196.34 |
| Resists | First : | 143.92 |
Second : | 168.1 |
| Pivot price | 139.32 |
|||
| Supports | First : | 115.02 |
Second : | 97.16 |
| MAs | MA(5) : | 141.59 |
MA(20) : | 132.48 |
| MA(100) : | 110.2 |
MA(250) : | 93 |
|
| MACD | MACD : | 8.8 |
Signal : | 8.8 |
| %K %D | K(14,3) : | 93.7 |
D(3) : | 95.2 |
| RSI | RSI(14): 80 |
|||
| 52-week | High : | 143.92 | Low : | 55.91 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IRTC ] has closed below upper band by 15.3%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 144.06 - 144.61 | 144.61 - 145.25 |
| Low: | 138.75 - 139.34 | 139.34 - 140.02 |
| Close: | 141.58 - 142.54 | 142.54 - 143.64 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Thu, 22 May 2025
Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews - Benzinga
Thu, 22 May 2025
iRhythm Technologies (IRTC) Sees Price Target Hiked by Citigroup - GuruFocus
Wed, 21 May 2025
iRhythm Technologies Lines Up Triple Conference Schedule: William Blair, Goldman Sachs, and Truist Securities - Stock Titan
Thu, 15 May 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC): Is Breakeven Near? - simplywall.st
Sun, 11 May 2025
Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 1 (%) |
| Held by Institutions | 111.2 (%) |
| Shares Short | 3,120 (K) |
| Shares Short P.Month | 2,920 (K) |
| EPS | -3.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.71 |
| Profit Margin | -15.9 % |
| Operating Margin | -19.5 % |
| Return on Assets (ttm) | -4.4 % |
| Return on Equity (ttm) | -111.2 % |
| Qtrly Rev. Growth | 20.2 % |
| Gross Profit (p.s.) | 13.44 |
| Sales Per Share | 19.37 |
| EBITDA (p.s.) | -1.83 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 48 (M) |
| Levered Free Cash Flow | 27 (M) |
| PE Ratio | -45.59 |
| PEG Ratio | 0 |
| Price to Book value | 52.65 |
| Price to Sales | 7.36 |
| Price to Cash Flow | 95.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|